Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates targeting rare neuromuscular and cardiac diseases, including Duchenne muscular dystrophy (Duchenne), Friedreich’s ataxia (FA), catecholaminergic polymorphic ventricular tachycardia (CPVT), TNNT2-mediated dilated cardiomyopathy, BAG3-mediated dilated cardiomyopathy, and additional fatal, genetic cardiac diseases. We are advancing a diverse pipeline and delivery platform in the pursuit of uniting experts in science, technology, disease management, and care. Patient-focused and founded by those directly impacted by Duchenne, Solid’s mission is to improve the daily lives of patients living with devastating rare diseases. We are seeking a Clinical Quality Assurance (CQA) Director who is responsible for establishing, implementing, and maintaining quality systems and risk‑management practices that ensure clinical trials are conducted in compliance with ICH‑GCP, applicable regulatory requirements, internal SOPs, and industry best practices. The individual is this role is responsible for quality management and oversight of clinical trials, clinical audit program, and risks across the clinical portfolio, in partnership with cross‑functional teams to proactively improve quality and trial execution. This role will report to the Head of Quality. The position is remote and full time. Solid’s Corporate Headquarters is located in Hood Park in Charlestown, MA and it is preferred that the individual in this role be available to come on-site periodically throughout the year.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
51-100 employees